For example, in August 2025, the Ozempic MDL judge entered an order saying that patients filing a gastroparesis claim must prove that their doctors used a gastric emptying study to diagnose them with gastroparesis
It must be prepared under USP 797 sterile standards and dispensed only with a valid prescription
They were also asked about GLP-RA use, including the specific drug, reasons for use, duration, side effects, and expected period of future use
Experts still don't know why GLP-1 users report taste changes, according to Steven Munger, professor at the University of Virginia
[2] [6] The medication is not recommended for patients with severe gastroparesis and requires careful monitoring in patients with diabetic retinopathy due to potential worsening with rapid glucose improvement
Discovery of a novel oral proteasome inhibitor to Block NLRP3 inflammasome activation with anti-inflammation activity